Parallel Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284M | Sell |
|
|||||
|
2025
Q1 | $220M | Buy |
|
|||||
|
2024
Q4 | $193M | Buy |
|
|||||
|
2024
Q3 | $176M | Sell |
|
|||||
|
2024
Q2 | $124M | Buy |
|
|||||
|
2024
Q1 | $96.1M | Buy |
|
|||||
|
2023
Q4 | $122M | Buy |
|
|||||
|
2023
Q3 | $101M | Sell |
|
|||||
|
2023
Q2 | $82.9M | Buy |
|
|||||
|
2023
Q1 | $80.7M | Sell |
|
|||||
|
2022
Q4 | $75.6M | Sell |
|
|||||
|
2022
Q3 | $96.6M | Buy |
|
|||||
|
2022
Q2 | $64.6M | Buy |
|
|||||
|
2022
Q1 | $47M | Buy |
|
|||||
|
2021
Q4 | $35.7M | Buy |
|
|||||
|
2021
Q3 | $34M | Buy |
|
|||||
|
2021
Q2 | $36.8M | Buy |
|
|||||
|
2021
Q1 | $37.2M | Buy |
|
|||||
|
2020
Q4 | $40.5M | Buy |
|
|||||
|
2020
Q3 | $22.5M | Sell |
|
|||||
|
2020
Q2 | $23.6M | Sell |
|
|||||
|
2020
Q1 | $16.7M | Hold |
|
|||||
|
2019
Q4 | $17M | Buy |
|
|||||
|
2019
Q3 | $18.1M | Buy |
|
|||||
|
2019
Q2 | $29K | Buy |
|